See more : CMC Metals Ltd. (CMB.V) Income Statement Analysis – Financial Results
Complete financial analysis of Merit Medical Systems, Inc. (MMSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merit Medical Systems, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- DIGITALIFT Inc. (9244.T) Income Statement Analysis – Financial Results
- Arcellx, Inc. (ACLX) Income Statement Analysis – Financial Results
- KemPharm, Inc. (KMPH) Income Statement Analysis – Financial Results
- NextDecade Corporation (NEXT) Income Statement Analysis – Financial Results
- Raen S.A. (RAE.WA) Income Statement Analysis – Financial Results
Merit Medical Systems, Inc. (MMSI)
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 1.15B | 1.07B | 963.88M | 994.85M | 882.75M | 727.85M | 603.84M | 542.15M | 509.69M | 449.05M | 394.29M | 359.45M | 296.76M | 257.46M | 227.14M | 207.77M | 190.67M | 166.59M | 151.40M | 135.95M | 116.23M | 104.04M | 91.45M | 78.00M | 68.40M | 60.60M | 50.50M | 42.60M | 33.30M | 25.40M | 18.40M | 10.50M | 4.40M | 1.40M |
| Cost of Revenue | 673.49M | 631.88M | 589.42M | 562.70M | 562.49M | 487.98M | 401.60M | 338.81M | 306.37M | 284.47M | 254.68M | 212.30M | 193.98M | 168.26M | 148.66M | 133.87M | 127.98M | 117.60M | 97.49M | 83.91M | 75.23M | 67.71M | 65.94M | 56.50M | 44.30M | 39.60M | 35.10M | 26.90M | 23.30M | 17.40M | 12.30M | 7.60M | 3.80M | 2.00M | 1.70M |
| Gross Profit | 583.87M | 519.10M | 485.33M | 401.18M | 432.37M | 394.77M | 326.25M | 265.03M | 235.78M | 225.22M | 194.37M | 181.99M | 165.47M | 128.50M | 108.80M | 93.27M | 79.79M | 73.08M | 69.09M | 67.49M | 60.72M | 48.52M | 38.10M | 34.94M | 33.70M | 28.80M | 25.50M | 23.60M | 19.30M | 15.90M | 13.10M | 10.80M | 6.70M | 2.40M | -300.00K |
| Gross Profit Ratio | 46.44% | 45.10% | 45.16% | 41.62% | 43.46% | 44.72% | 44.82% | 43.89% | 43.49% | 44.19% | 43.28% | 46.16% | 46.03% | 43.30% | 42.26% | 41.06% | 38.40% | 38.33% | 41.48% | 44.58% | 44.67% | 41.74% | 36.62% | 38.21% | 43.21% | 42.11% | 42.08% | 46.73% | 45.31% | 47.75% | 51.57% | 58.70% | 63.81% | 54.55% | -21.43% |
| Research & Development | 82.73M | 75.51M | 71.25M | 57.54M | 65.62M | 59.53M | 51.40M | 45.23M | 40.81M | 36.63M | 33.89M | 27.80M | 21.94M | 15.34M | 11.17M | 9.16M | 8.69M | 8.58M | 6.99M | 5.08M | 4.63M | 4.01M | 4.12M | 3.86M | 3.60M | 3.20M | 4.40M | 2.50M | 2.30M | 2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 373.68M | 342.53M | 335.69M | 297.72M | 327.27M | 276.02M | 229.13M | 184.40M | 156.35M | 147.89M | 128.64M | 122.11M | 104.50M | 87.62M | 64.79M | 53.13M | 48.13M | 45.49M | 38.58M | 35.07M | 30.47M | 27.73M | 24.04M | 23.30M | 20.40M | 17.50M | 15.70M | 14.30M | 12.80M | 10.20M | 9.10M | 8.00M | 4.70M | 2.10M | 0.00 |
| Other Expenses | 3.52M | 966.00K | -2.51M | -2.28M | -537.00K | 63.00K | -872.00K | -773.00K | -386.00K | 18.00K | -216.00K | -1.65M | 5.84M | 8.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| Operating Expenses | 459.93M | 418.04M | 406.94M | 355.26M | 392.89M | 335.55M | 280.54M | 229.63M | 197.16M | 184.53M | 162.53M | 149.90M | 126.44M | 102.95M | 75.96M | 62.29M | 56.82M | 54.07M | 45.57M | 40.15M | 35.09M | 31.74M | 28.16M | 31.48M | 27.60M | 23.50M | 22.80M | 19.20M | 16.80M | 13.90M | 10.50M | 9.10M | 5.20M | 2.30M | 100.00K |
| Cost & Expenses | 1.13B | 1.05B | 996.36M | 917.96M | 955.38M | 823.53M | 682.14M | 568.44M | 503.53M | 468.99M | 417.21M | 362.20M | 320.42M | 271.21M | 224.62M | 196.16M | 184.80M | 171.66M | 143.06M | 124.06M | 110.32M | 99.45M | 94.10M | 87.99M | 71.90M | 63.10M | 57.90M | 46.10M | 40.10M | 31.30M | 22.80M | 16.70M | 9.00M | 4.30M | 1.80M |
| Interest Income | 2.46M | 439.00K | 769.00K | 604.00K | 0.00 | 1.20M | 381.00K | 81.00K | 272.00K | 217.00K | 255.00K | 226.00K | 129.00K | 34.00K | 178.00K | 781.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.51M | 6.34M | 5.26M | 9.99M | 12.41M | 10.36M | 7.74M | 8.80M | 6.23M | 8.83M | 8.04M | 604.00K | 789.00K | 596.00K | 28.00K | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 101.29M | 92.20M | 95.78M | 106.82M | 104.36M | 69.55M | 53.58M | 43.76M | 37.43M | 35.93M | 32.54M | 22.53M | 19.19M | 14.86M | 12.27M | 10.24M | 9.31M | 8.10M | 5.64M | 4.49M | 4.23M | 4.38M | 4.56M | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| EBITDA | 231.44M | 181.15M | 153.45M | 102.71M | 121.00M | 129.43M | 97.29M | 78.66M | 74.85M | 76.33M | 60.43M | 50.76M | 52.93M | 32.24M | 45.39M | 42.10M | 32.41M | 19.01M | 23.52M | 27.34M | 30.37M | 21.16M | 14.50M | 7.78M | 9.70M | 8.10M | 5.40M | 6.80M | 4.20M | 3.60M | 4.00M | 2.80M | 2.00M | 300.00K | -300.00K |
| EBITDA Ratio | 18.41% | 16.91% | 16.04% | 4.59% | 3.88% | 6.85% | 6.21% | 5.75% | 7.10% | 8.03% | 7.10% | 7.78% | 10.89% | 8.62% | 12.83% | 18.11% | 15.52% | 14.25% | 17.56% | 20.95% | 21.21% | 18.22% | 13.19% | 8.95% | 12.44% | 11.99% | 8.91% | 13.47% | 9.86% | 10.51% | 15.35% | 15.22% | 18.10% | 4.55% | -21.43% |
| Operating Income | 123.94M | 87.56M | 60.92M | -62.58M | -65.71M | 58.62M | 33.07M | 34.88M | 37.54M | 40.17M | 27.84M | 29.64M | 33.19M | 17.20M | 32.85M | 30.98M | 22.97M | 19.01M | 23.52M | 27.34M | 25.63M | 16.78M | 9.94M | 3.46M | 6.10M | 5.30M | 2.70M | 4.40M | 2.50M | 2.00M | 2.60M | 1.70M | 1.50M | 100.00K | -400.00K |
| Operating Income Ratio | 9.86% | 7.61% | 5.67% | -6.49% | -6.60% | 6.64% | 4.54% | 5.78% | 6.92% | 7.88% | 6.20% | 7.52% | 9.23% | 5.80% | 12.76% | 13.64% | 11.06% | 9.97% | 14.12% | 18.06% | 18.85% | 14.43% | 9.55% | 3.78% | 7.82% | 7.75% | 4.46% | 8.71% | 5.87% | 6.01% | 10.24% | 9.24% | 14.29% | 2.27% | -28.57% |
| Total Other Income/Expenses | -11.86M | -19.44M | -7.00M | -11.67M | -13.24M | -9.10M | 2.81M | -9.49M | -6.34M | -8.59M | -8.01M | -2.02M | -315.00K | -416.00K | 247.00K | 861.00K | 429.00K | 174.00K | 379.00K | 666.00K | 885.00K | -13.00K | -151.23K | -2.69M | -1.40M | -1.10M | -1.00M | -900.00K | -600.00K | 100.00K | 0.00 | 0.00 | 200.00K | 0.00 | 400.00K |
| Income Before Tax | 112.09M | 82.63M | 53.92M | -13.23M | 2.19M | 49.52M | 35.88M | 25.39M | 31.20M | 31.57M | 19.84M | 27.62M | 32.88M | 16.79M | 33.09M | 31.85M | 23.40M | 19.18M | 23.90M | 28.01M | 27.02M | 16.76M | 9.79M | 773.85K | 4.70M | 4.20M | 1.70M | 3.50M | 1.90M | 2.10M | 2.60M | 1.70M | 1.70M | 100.00K | -400.00K |
| Income Before Tax Ratio | 8.91% | 7.18% | 5.02% | -1.37% | 0.22% | 5.61% | 4.93% | 4.20% | 5.75% | 6.19% | 4.42% | 7.00% | 9.15% | 5.66% | 12.85% | 14.02% | 11.26% | 10.06% | 14.35% | 18.50% | 19.88% | 14.42% | 9.41% | 0.85% | 6.03% | 6.14% | 2.81% | 6.93% | 4.46% | 6.31% | 10.24% | 9.24% | 16.19% | 2.27% | -28.57% |
| Income Tax Expense | 17.68M | 8.11M | 5.46M | -3.39M | -3.26M | 7.50M | 8.36M | 5.27M | 7.40M | 8.60M | 3.27M | 7.91M | 9.83M | 4.33M | 10.56M | 11.12M | 7.81M | 6.88M | 8.12M | 10.07M | 9.73M | 5.45M | 3.05M | -52.71K | 1.50M | 1.70M | 900.00K | 1.30M | 700.00K | 800.00K | 800.00K | 500.00K | 400.00K | -100.00K | 400.00K |
| Net Income | 94.41M | 74.52M | 48.45M | -9.84M | 5.45M | 42.02M | 27.52M | 20.12M | 23.80M | 22.97M | 16.57M | 19.71M | 23.04M | 12.46M | 22.53M | 20.73M | 15.59M | 12.30M | 15.78M | 17.93M | 17.30M | 11.31M | 6.74M | 826.56K | 3.20M | 2.50M | 800.00K | 2.20M | 1.20M | 1.30M | 1.80M | 1.20M | 1.30M | 100.00K | -400.00K |
| Net Income Ratio | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | 4.76% | 3.78% | 3.33% | 4.39% | 4.51% | 3.69% | 5.00% | 6.41% | 4.20% | 8.75% | 9.13% | 7.50% | 6.45% | 9.47% | 11.84% | 12.72% | 9.73% | 6.47% | 0.90% | 4.10% | 3.65% | 1.32% | 4.36% | 2.82% | 3.90% | 7.09% | 6.52% | 12.38% | 2.27% | -28.57% |
| EPS | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 | 0.59 | 0.35 | 0.64 | 0.60 | 0.46 | 0.36 | 0.47 | 0.54 | 0.53 | 0.37 | 0.24 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| EPS Diluted | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 | 0.58 | 0.34 | 0.63 | 0.58 | 0.44 | 0.35 | 0.46 | 0.52 | 0.51 | 0.34 | 0.23 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| Weighted Avg Shares Out | 57.59M | 56.81M | 56.15M | 55.43M | 55.08M | 52.27M | 48.81M | 44.41M | 44.04M | 43.14M | 42.61M | 42.18M | 39.09M | 35.29M | 35.01M | 34.71M | 34.28M | 34.17M | 33.56M | 32.88M | 31.56M | 30.11M | 28.17M | 26.84M | 26.18M | 25.76M | 25.25M | 24.48M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
| Weighted Avg Shares Out (Dil) | 58.36M | 57.67M | 57.36M | 55.43M | 56.24M | 53.93M | 50.10M | 44.86M | 44.51M | 43.41M | 42.88M | 42.61M | 39.73M | 35.98M | 35.76M | 35.69M | 35.26M | 35.31M | 34.81M | 34.61M | 33.79M | 32.80M | 29.84M | 27.29M | 26.27M | 26.00M | 25.25M | 24.59M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
SOUTH JORDAN, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced the pricing of $650.0 million aggregate principal amount of 3.00% Convertible Senior Notes due 2029...
Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
SOUTH JORDAN, Utah, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced today that it intends to offer, subject to market conditions and other factors, $550.0 million...
PDCO or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).
How Much Upside is Left in Merit Medical (MMSI)? Wall Street Analysts Think 25.31%
The mean of analysts' price targets for Merit Medical (MMSI) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside...
Merit Medical Caught Up In The Med-Tech Downswing
Merit Medical delivered another quarter ahead of expectations, with strong growth in peripheral intervention, OEM manufacturing, and endoscopy, driving 7% organic revenue growth coupled with opex leverage. Assets acquired from AngioDynamics are already outperforming initial expectations, and performance in several...
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).
Merit Medical (MMSI) Q3 Earnings Top Estimates, FY23 View Revised
Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the third quarter.
Merit Medical Systems, Inc. (MMSI) Q3 2023 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ET Company Participants Fred Lampropoulos – Founder, Chairman and Chief Executive Officer Brian Lloyd – Chief Legal Officer and Corporate Secretary Raul Parra –...
Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago...
Merit Medical (MMSI) Beats Q3 Earnings and Revenue Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.64 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports